240 related articles for article (PubMed ID: 29945350)
1. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
Zarei AE; Redwan EM
Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
[TBL] [Abstract][Full Text] [Related]
2. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. II. Antibodies subclasses.
Zarei AE; Redwan EM
Hum Antibodies; 2019; 27(1):1-11. PubMed ID: 30103308
[TBL] [Abstract][Full Text] [Related]
3. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. III. Antibodies avidity.
Zarei AE; Redwan EM
Hum Antibodies; 2019; 27(1):13-22. PubMed ID: 30103310
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
Ladhani S; Ramsay M; Flood J; Campbell H; Slack M; Pebody R; Findlow J; Newton E; Wilding M; Warrington R; Crawford H; Min S; Gray K; Martin S; Frankland S; Bokuvha N; Laher G; Borrow R
Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171823
[TBL] [Abstract][Full Text] [Related]
5. Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.
Collins S; Litt D; Almond R; Findlow J; Linley E; Ramsay M; Borrow R; Ladhani S
J Infect; 2018 Apr; 76(4):335-341. PubMed ID: 29289561
[TBL] [Abstract][Full Text] [Related]
6. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules.
Hong E; Terrade A; Denizon M; Aouiti-Trabelsi M; Falguières M; Taha MK; Deghmane AE
BMC Infect Dis; 2021 Jul; 21(1):715. PubMed ID: 34330228
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
Townsend K; Ladhani SN; Findlow H; Borrow R
Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Haemophilus influenzae Seroprevalence in Serum Samples Collected from 0- to 5-Year-Old Japanese Children in 1980, 1995, 2010, and 2012.
Arai S; Satoh H; Okuno H; Morino S; Oishi K; Tanaka-Taya K
Jpn J Infect Dis; 2020 Jan; 73(1):51-54. PubMed ID: 31474695
[TBL] [Abstract][Full Text] [Related]
10. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
Zarei AE; Linjawi MH; Redwan EM
Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
[TBL] [Abstract][Full Text] [Related]
11. Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.
Perrett KP; John TM; Jin C; Kibwana E; Yu LM; Curtis N; Pollard AJ
Clin Infect Dis; 2014 Apr; 58(7):949-59. PubMed ID: 24403544
[TBL] [Abstract][Full Text] [Related]
12. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
[TBL] [Abstract][Full Text] [Related]
13. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease.
Hallander HO; Lepp T; Ljungman M; Netterlid E; Andersson M
APMIS; 2010 Nov; 118(11):878-87. PubMed ID: 20955461
[TBL] [Abstract][Full Text] [Related]
14. Pattern of functional antibody activity against Haemophilus influenzae type B (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine.
Matos DC; Silva AM; Neves PC; Martins RM; Homma A; Marcovistz R
Braz J Med Biol Res; 2009 Dec; 42(12):1242-7. PubMed ID: 19893995
[TBL] [Abstract][Full Text] [Related]
15. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.
Breukels MA; Jol-van der Zijde E; van Tol MJ; Rijkers GT
Clin Infect Dis; 2002 Jan; 34(2):191-7. PubMed ID: 11740707
[TBL] [Abstract][Full Text] [Related]
16. Haemophilus influenzae type b reemergence after combination immunization.
Johnson NG; Ruggeberg JU; Balfour GF; Lee YC; Liddy H; Irving D; Sheldon J; Slack MP; Pollard AJ; Heath PT
Emerg Infect Dis; 2006 Jun; 12(6):937-41. PubMed ID: 16707049
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian.
Redwan el-RM; Elsawy A
Hum Antibodies; 2005; 14(1-2):23-6. PubMed ID: 16424597
[TBL] [Abstract][Full Text] [Related]
18. Natural immunity to Haemophilus influenzae type B in children of Ankara, Turkey.
Ocaktan E; Ozyurda F; Akar N
Pediatr Int; 2004 Jun; 46(3):280-4. PubMed ID: 15151543
[TBL] [Abstract][Full Text] [Related]
19. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae type b capsular polysaccharide antibody levels in Japanese young patients with hematological malignancies and asplenia.
Takeshita K; Ishiwada N; Takeuchi N; Takahashi Y; Fukasawa C; Hishiki H; Hoshino T; Shimojo N
J Infect Chemother; 2020 Sep; 26(9):959-962. PubMed ID: 32402734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
